Skip to main content
Premium Trial:

Request an Annual Quote

Enpicom, Cytura Therapeutics to Develop Cancer Diagnostic

NEW YORK (GenomeWeb) – Enpicom and Cytura Therapeutics have partnered to develop a diagnostic assay for early cancer detection, the Netherlands-based companies announced on Wednesday.

Enpicom develops biomedical software including its recently launched ImmunoGenomiX platform for immune sequencing data analysis, while Cytura is developing cancer drugs targeting genomic instability.

Under the alliance, which is being supported with an unspecified amount of funding from the Dutch government, the companies will use sequencing- and machine learning-based methods to quantify genomic instability-causing mutations in blood cells. The mutations will be the basis for a future diagnostic test.

Additional details were not disclosed.

"Genomic instability is the main driving force of cancer initiation, development, and therapy resistance," Cytura CEO Ad van Gorp said in a statement. "The R&D partnership will make early detection of genomic instability possible, enabling early diagnosis and interference with the compounds of Cytura."

Earlier this year, Enpicom partnered with molecular diagnostics laboratory DDL to develop an immune repertoire sequencing and analysis service. About a year ago, the company and collaborator Glycostem Therapeutics received Dutch government funding to develop technology for predicting cancer patient response to immunotherapy.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.